Last reviewed · How we verify
Caerulein (CERULETIDE)
Ceruletide is a marketed diagnostic aid that stimulates digestive processes by mimicking the natural hormone cholecystokinin through binding to the cholecystokinin receptor type A. Its key competitive advantage lies in its specific mechanism of action and the protection of its key composition patent until 2028. The primary risk is the presence of off-patent competitors such as magnesium sulfate, which may limit market exclusivity and pricing power.
At a glance
| Generic name | CERULETIDE |
|---|---|
| Drug class | ceruletide |
| Target | Cholecystokinin receptor type A |
| Modality | Recombinant protein |
| Therapeutic area | Gastroenterology |
| Phase | FDA-approved |
| First approval | 1982 |
Approved indications
- Diagnostic aid
Common side effects
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |